Loading Results

Neurology

Showing   of 28 results

Amrou Sarraj, MD

University Hospitals Awarded $7 Million by PCORI to Study Endovascular Thrombectomy in Patients Presenting Beyond 24 Hours

Dr. Amrou Sarraj will lead the study, which aims to provide deterministic evidence of clinical benefit due to addition of endovascular thrombectomy to standard medical care in this population.

Researchers Pieper, Sridharan and Qi

New Study Shows that Chronic Neurodegeneration can be Prevented after Traumatic Brain Injury

University Hospitals and Case Western Reserve University research team reports a novel treatment after traumatic brain injury that prevents progression to chronic neurodegeneration.

UH Cleveland Medical Center

University Hospitals Nationally Recognized for High-Quality Stroke Care

The American Heart Association presents Get With The Guidelines® - Stroke awards for proven dedication to ensuring all stroke patients have access to best practices and life-saving care.

Researchers Identify Potential Therapeutic Target for Management of Thirst Disorders

University Hospitals and Case Western Reserve University team show cerebellum is a thirst-modulating brain center.

CR Awards 2024 thumb

Two UH Physician-Scientists to Receive 2024 Top Ten Clinical Research Achievement Awards

Mehdi Shishehbor, DO, MPH, PhD, and Amrou Sarraj, MD, will receive honors from the Clinical Research Forum in a ceremony to be held April 2 in Las Vegas.

Amrou Sarraj, MD

International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes

Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.

Neuro testing-Getty images

University Hospitals Now Offering FDA-Approved Medication for Treatment of Alzheimer’s Disease

UH Brain Health & Memory Center Begins LEQEMBI® (lecanemab) Infusions for Patients

Camilla Kilbane, MD

University Hospitals Selected as Study Site for the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study

BLAAC PD is an initiative of GP2 in a dedicated effort to better understand the genetic basis of Parkinson’s disease (PD) among underrepresented populations by genotyping more than 150,000 individuals from around the world.

Results are loading...